The expression of IQGAP3 in renal cell carcinoma, its correlation with prognosis or chemoradiotherapy sensitivity, the molecular mechanism involved in tumor malignant progression will help further biomarkers identification and combination therapy exploration. This evidence concerns the gene IQGAP3 and neoplasm.